This summer, Germany was ravaged by an E. coli outbreak that sickened 3,500 people and killed 50. Several research groups around the world quickly mobilized their labs to sequence the bug's genome and analyze it, identifying effective treatment options within days. The University of Maryland School of Medicine's David Rasko was one of the American researchers who teamed up with a group from Denmark's Staten Serums Institut to sequence the bacterium and investigate the epidemiology of the outbreak.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.